In 2023, Warren Hosseinion, M.D. earned $734.39K in total compensation at Nutex Health Inc., primarily from $710.18K salary. Most recently acquired 200,000 shares in Sep 2022. Currently holds stock worth $632.69K. Has donated $4.51M in stock to charitable causes.
Compensation History
Annual executive compensation data for Warren Hosseinion, M.D., including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$734.39K
Salary
$710.18K
Bonus
$0.00
Other
$24.21K
Salary
$710.18KBoard Justification
The compensation committee aims to keep salaries in line with the external job market and considers each NEO’s experience, skills, knowledge, responsibilities, and performance.
Bonus
$0.00Board Justification
No bonuses were awarded for fiscal year 2023.
Other Compensation
$24.21KBoard Justification
Reflects health, dental and life insurance premiums, and 401(k) employer match paid for the applicable year.
Restricted Stock
Board Justification
No stock awards vested in 2023.
Performance Metrics
No bonuses were awarded for fiscal year 2023.
Warren Hosseinion, M.D.
Founder and Ex-CEO of Nutex Health Inc.
Education
M.D. from Georgetown University School of Medicine, M.S. in Physiology and Biophysics from Georgetown University, B.S. in Biology from University of San Francisco.
Field of Expertise
Healthcare & Life Sciences - Medicine
Sector of Economy
Healthcare
Born
January 1, 1971 - 54 years ago
CEO of Nutex Health Inc. for
0 years 7 months (Jul 2020 - Feb 2021)
Previous Experience
Co-Founder of Apollo Medical Holdings, Inc., served as CEO from July 2008 to December 2017.
Holdings
Track Warren Hosseinion, M.D.'s stock holdings and portfolio value over time.
Charitable Transactions
24,388.8 shares
NUTX
Recent Charitable Transactions
141,000 shares
NUTX
Sep 22, 2023
Charity
102,888 shares
NUTX
May 5, 2022
Charity
Insider Trading
Warren Hosseinion, M.D.'s recent stock transactions, purchases, and sales filed with the SEC.
141,000 shares
NUTX
Sep 22, 2023
Charity
$482.00K
NUTX at $2.41/share
Sep 14, 2022
Sale
$729.05K
NUTX at $2.92/share
Sep 7, 2022
Sale
$914.19K
NUTX at $2.61/share
Sep 1, 2022
Sale
102,888 shares
NUTX
May 5, 2022
Charity
Rivals
Compare Warren Hosseinion, M.D. with competitor CEOs and industry peers.